R2304283 |
NLX-204HCl |
NLX-204 is a potent, selective agonist of ERK1/2 phosphorylation-preferring sero
|
R2304284 |
Practolol |
Practolol is a potent and selective β1-adrenergic receptor antagonist. Practolol
|
R2304285 |
Bisindolylmaleimide VIII acetate |
Bisindolylmaleimide VIII acetate (Ro 31-7549 acetate) is a potent and selective
|
R2304286 |
Ro0335 |
RO-0335 is a novel and potent diphenylether nonnucleoside reverse transcriptase
|
R2304287 |
CITCO |
CITCO, an imidazothiazole derivative, is a selective Constitutive androstane rec
|
R2304288 |
JNJ-18038683 |
JNJ-18038683 is a 5-Hydroxytryptamine Type 7 (5-HT7) receptor antagonist, with p
|
R2304289 |
Aumitin |
Aumitin is a diaminopyrimidine-based autophagy inhibitor which inhibits mitochon
|
R2304290 |
RAD51-IN-1 |
RAD51-IN-1, a derivative of B02, is a potent inhibitor of RAD51. RAD51-IN-1 can
|
R2304291 |
MRGPRX1 agonist 1 |
MRGPRX1 agonist 1 is a highly potent agonist of MRGPRX1 (Mas-related G-protein-c
|
R2304292 |
Menin-MLL inhibitor 20 |
Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with a
|
R2304293 |
SMS1-IN-1 |
SMS1-IN-1, compound SAPA 1j, is a novel and the most potent sphingomyelin syntha
|
R2304294 |
LMPTP INHIBITOR 1 dihydrochloride |
LMPTP INHIBITOR 1 (dihydrochloride) is a selective inhibitor of low molecular we
|
R2304295 |
Gemfibrozil 1-O-β-glucuronide |
Gemfibrozil 1-O-β-Glucuronide, a metabolite of Gemfibrozil (CI-719; HY-B0258), i
|
R2304296 |
SN-38 glucuronide (SN-38G) |
SN-38 glucuronide is an inactive metabolite of the cancer drug Irinotecan. Irino
|
R2304297 |
PF-06821497 |
PF-06821497 is a selective inhibitor of EZH2 with significant tumor growth inhib
|
R2304298 |
Dydrogesterone |
Dydrogesterone is a potent, orally active progestogen indicated in a wide variet
|
R2304299 |
7-CKA sodium salt |
7-Chlorokynurenic acid sodium salt (7-CKA sodium salt) is a potent and selective
|
R2304300 |
AM103 |
AM 103 is a potent and selective FLAP inhibitor, with an IC50 value of 4.2 nM.
|
R2304301 |
E-7386 |
E-7386 is an orally active CBP/beta-catenin modulator.
|
R2304302 |
Iptacopan (LNP023) |
Iptacopan (LNP023) is a first-in-class, orally bioavailable, highly potent and h
|
R2304303 |
VH032 |
VH032 is a VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) pro
|
R2304304 |
UDP-D-Glucose disodium salt |
Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) is the p
|
R2304305 |
(S)-PF-06873600 |
(S)-PF-06873600 is the S enantiomer of PF-06873600 which is an inhibitor of CDK.
|
R2304306 |
SB9200;GS-9992;Inarigivir soproxil |
Inarigivir soproxil (SB9200) is an agonist of innate immunity and shows potent a
|
R2304307 |
Y-27632 |
Y-27632 is an orally active, ATP-competitive inhibitor of ROCK-I and ROCK-II, wi
|